BSG and prostate cancer: Through this pathway, CD147 promotes EMT-driven metastasis in prostate cancer by disrupting the β-catenin/E-cadherin complex, resulting in β-catenin nuclear translocation, activation of EMT-related genes, and E-cadherin loss (61).